ArticleScientific reports2025
Computational approaches in drug chemistry leveraging python powered QSPR study of antimalaria compounds by using artificial neural networks.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Integrating fuzzy logic and neural networks with multi-criteria decision-making for intelligent evaluation of drug compound design attributes.Scientific reports · 2026Article
- QSPR analysis of the drugs used to treat renal failure and its complications using degree and modified reverse degree indices.Scientific reports · 2026Article
- Predictive modeling for physicochemical properties of β-lactam antibiotics through eigenvalue based topological indices and non linear regression techniques.Scientific reports · 2026Article
- QSPR modelling of PPI drugs using hybrid topological indices.Frontiers in chemistry · 2026Article
- QSPR analysis of the drugs used to treat major depressive disorder using degree and neighborhood degree based indices.Frontiers in chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The application of Machine Learning has become a revolutionary instrument in the domain of pharmaceutical research. Machine learning enables the modelling of Quantitative Structure Property Relationship, a crucial task in forecasting the physiochemical characteristics of drugs. In this study we utilized machine learning algorithms namely Artificial Neural Networks and Random Forest to predict physiochemical characteristics of Anti-malaria drugs. These models utilize several topological indices global variables quantifying the connectivity and geometric characteristics of molecules to estimate the ability of prospective antimalarial compounds to interact with the target enzyme and other physicochemical parameters. Molecular descriptors such as size, shape, and electronic structure indices are a way of mapping molecular properties into a set of quantitative data that can be analyzed by Machine Learning techniques. By carrying out regression analysis with the help of Artificial Neural Networks and Random Forest, the corresponding changes in the molecular structures and their effects on effectiveness and properties of the potential drugs can be predicted, thereby supporting the search for new therapeutic compounds. Machine learning not only observe the drug development process but also facilitates to look at chemical datasets with respect to high order non-linear relationship, which are essential to improve antimalarial drug candidates and pharmacokinetic properties.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.